Adelaide Almeida, Researcher at CESAM/DBio, co-authored a paper recently published in The Lancet Infectious Diseases, a journal with an Impact Factor of 21.372 (5-Year Impact Factor: 19.297)
The work “Photoantimicrobials—are we afraid of the light?” provide a Personal View about the abusive use of conventional antimicrobial drugs, which have been assumed as miraculous cure-alls for the past 80 years, causing increasing antimicrobial drug resistance. As alternative, the authors raise awareness of novel photoantimicrobial technologies that offer a viable substitute to conventional drugs in many relevant application fields, and could thus slow the pace of resistance development. The authors discussed photoantimicrobials (light-activated molecules that act locally via the in-situ production of highly reactive oxygen species) and their uses and prospects for adoption as mainstream clinical antimicrobials in the fight against conventional drug resistance.
More details in: http://uaonline.ua.pt/pub/detail.asp?c=48566&lg=pt
Full paper: http://dx.doi.org/10.1016/S1473-3099(16)30268-7